Mailbox
Favorites
Boards
The Hangout
NASDAQ
NYSE
OTC Markets
All Boards
Whats Hot!
Recent Activity
Most Viewed Boards
Most Viewed Posts
Most Posted
Most Followed
Top Boards
Newest Boards
Newest Members
Blog
Recent Blog Posts
Recently Updated
News
Stocks
Crypto
Investing
Business
Markets
Economy
Real Estate
Personal Finance
Market Movers
Interactive Charts
Login - Join Now FREE!
Home
›
Stock Message Boards
›
Stock Boards
›
Innovation Pharmaceuticals Inc (IPIX) Message Board
Search
Search Type
Board
Post
Member
Hide Board Information
Show Board Information
Innovation Pharmaceuticals Inc IPIX
Board Mod:
Dynabolic
Asst Mods:
Kelt
Drano
NotRichYet2
Loose Lips
someconcerns
Mo
Last Post: 11/06/2024 9:48:45 AM
Board Marks: 278
Posts Today: 0
Board Views Today: 4746
Innovation Pharmaceuticals Inc. (IPIX)
Company Website:
http://www.ipharminc.com/
IPIX Stock Message Board Intro
Innovation Pharmaceuticals Inc (OTCMRKTS: IPIX) Stock Message Board
IPIX Company Profile
IPIX Time & Sales
IPIX Recent News
IPIX Filings
IPIX Financials
IPIX Buy Rating
Create New Post
View All Posts
Board Mark
Banned
Post
Subject
Author
Posted On
64595
Yesterdays PR was terrific. Brilacidin was found
(15)
farrell
05/20/2020 8:55:40 PM
70679
IPIX .. NR (non retail) would normally be showing
(16)
4kids
10/28/2021 12:32:05 PM
72046
Innovation Pharmaceuticals Announces Publication
(7)
Mo
10/04/2022 12:13:17 PM
72181
WAKEFIELD, MA / January 4, 2023 BT
(7)
Drano
01/09/2023 8:51:41 AM
68981
IPIX was already working on a simple capsule (not
(3)
petemantx
03/16/2021 9:52:15 AM
68978
Very interesting. This is opposite of what I have
Zadie
03/16/2021 8:55:03 AM
68975
Excellent! Successful covid trial could very well
(4)
williamsc
03/14/2021 8:33:59 PM
68973
You are correct. I was associating IBD
thefamilyman
03/14/2021 12:13:42 PM
68971
https://pbs.twimg.com/media/Es2Tky_XAAEHx6U?forma
(7)
AlanC
03/14/2021 11:15:43 AM
68969
That PR confirms my point.The large intestine
(6)
Kelt
03/14/2021 9:43:24 AM
68968
Tune up for 3/19 rule change? Wash trades have
(5)
AlanC
03/14/2021 9:40:33 AM
68967
@ Kelt - I sent you a PM thinking I did not have
(9)
thefamilyman
03/13/2021 10:59:43 PM
68966
Do you think the volume of 775K (less than 1/3 of
DrTim
03/13/2021 10:50:21 PM
68965
If I recall,oral B for IBD /Crohns was designed
(9)
Kelt
03/13/2021 9:44:03 PM
68964
It would be like Nitroglycerin; blowing up the
(1)
gchgch
03/13/2021 8:56:31 PM
68963
Possibly use under the tongue as a direct route
(1)
williamsc
03/13/2021 5:26:52 PM
68960
Seems that the effectiveness of the drug
(3)
bandg
03/13/2021 2:53:51 PM
68959
More hearings 3/17 with SEC and DTCC under fire
(6)
AlanC
03/13/2021 2:17:00 PM
68957
I heard Dr. Fauci on TV yesterday indicating that
Chemdeps
03/13/2021 1:55:24 PM
68954
My definition now of a good week is how many new
(3)
petemantx
03/12/2021 4:50:14 PM
68951
Volume is very low so far today. Just under
(5)
Drano
03/12/2021 1:24:18 PM
68949
I've asked the administrator. When I get a
(3)
someconcerns
03/12/2021 12:23:47 PM
68947
Does anyone know what just happened to IHangout?
gchgch
03/12/2021 11:22:52 AM
68945
Below are several Drug SI's for Covid-19
(8)
farrell
03/10/2021 11:19:05 PM
68944
I have been trying to answer the same question
(1)
crashco
03/10/2021 9:25:28 PM
68943
In lookin for Selectivity Indexes to compare
(1)
Boneysteak
03/10/2021 9:18:14 PM
68942
Machine Learning Model: Where are candidates
(6)
crashco
03/10/2021 7:17:49 PM
68940
No matter where Brilacidin stands in the study,
(8)
petemantx
03/10/2021 3:50:14 PM
68939
As I stated, not an exhaustive or complete
(1)
crashco
03/10/2021 3:32:44 PM
68938
Solid work! Thank you. Seems like Ritonavir is
(4)
Ultimate
03/10/2021 3:29:38 PM
68937
clinicaltrial.gov Search criteria: Indication
(4)
crashco
03/10/2021 3:22:39 PM
68934
Yaaa I know and will still be vigilant in staying
NotRichYet2
03/10/2021 9:23:38 AM
68933
I see our resident idiot has been watching Full
(1)
scgmck1
03/10/2021 8:59:41 AM
68931
Thanks! I love to see third party votes of
(6)
Ultimate
03/10/2021 8:01:59 AM
68930
$IPIX ICYMI
(3)
TonyCorvette
03/10/2021 7:47:40 AM
68929
Brilacidin found to have a high theoretical viral
(3)
kerdom
03/10/2021 7:42:39 AM
68928
Attached is an article regarding the
(6)
petemantx
03/09/2021 6:01:52 PM
68927
Today I got my first of two vaccine shots
NotRichYet2
03/09/2021 4:10:44 PM
68926
I hope that you are right. But since the DTCC is
(2)
thefamilyman
03/09/2021 2:30:19 PM
68925
I thought that this was a proposed rule change
(1)
thefamilyman
03/09/2021 1:55:21 PM
68923
Correct DTCC IS TRYING to cover its arse as is
(9)
AlanC
03/09/2021 10:51:02 AM
68922
I would encourage everyone to watch the YouTube
(5)
DrTim
03/09/2021 10:11:01 AM
68920
I am going to break my own rule just this one
(13)
Mo
03/08/2021 10:43:40 PM
68919
Love it. GME has them by the short hairs. Fun to
(7)
AlanC
03/08/2021 7:38:09 PM
68917
Here is a you tube video my son sent me this
(3)
falcon74
03/08/2021 2:49:43 PM
68916
Just saw Fauci on TV explaining how they are now
(4)
Chemdeps
03/08/2021 11:44:44 AM
68915
SI-426
(1)
crashco
03/08/2021 11:02:37 AM
68914
Brilacidin has a history of success in human
(4)
mtnman213
03/08/2021 9:29:25 AM
68913
This is big news and imho will cause those that
(5)
AlanC
03/08/2021 8:11:22 AM
68912
Clinical Trials Site Updated. Added site, Russia
(2)
crashco
03/08/2021 6:38:24 AM
68911
This week's clinical trial failures for
(12)
Drano
03/07/2021 6:40:58 PM
68908
Since the PR came out Friday mid-day, it is
(8)
Chemdeps
03/07/2021 3:25:59 PM
68906
Good point. I still think that even if BARDA is
(9)
Ultimate
03/06/2021 1:04:02 PM
68903
Let's not forget that the BARDA grant program for
(5)
Drano
03/06/2021 11:25:14 AM
Newer
Older
Recent Articles
International Paper Looks to Expand with DS Smith Acquisition
Elon Musk vs. Neil deGrasse Tyson: A Debate on Mars Exploration
Novo Nordisk Shares Climb on New Obesity Care Coverage Proposal
Enwell Energy Restarts Operations in Ukraine's Fields
Thomas Belcher Takes on Senior Sales Role at Capital Square
Shareholder Approval for SLF Realisation Fund's Delisting
NexLiving Communities Achieves Record Growth and Dividends
Frasers Group Expands Reach with Holdsport Acquisition
Axsome Therapeutics' AXS-12: A New Hope for Narcolepsy
Leadership Overhaul at ScottsMiracle-Gro: New Directions Ahead
KalVista Pharmaceuticals Strengthens Board with New Appointment
Sarepta Therapeutics Expands Offerings with Licensing Deal
European Central Bank Faces Challenges Amid Weak Growth Signs
UK Retailers Face New Challenges Amid Falling Confidence Levels
JPMorgan Upgrades Enagás: A Positive Shift for Investors
Burlington Stores Faces Challenges Amid Missed Q4 Expectations
Analog Devices Reports Strong Q4 Results with Upbeat Guidance
Kohl's Adjusts Sales Expectations Ahead of Holiday Shopping
Kohl's Faces Challenges as Third-Quarter Results Disappoint
Best Buy Lowers Profit and Sales Outlook Amid Consumer Caution
Economic Concerns Weigh on Gold and Australian Dollar Trends
Exploring the Impact of Autonomous Vehicles on Key Stocks
Market Outlook: Stocks and AI Trends Amid Tariff Concerns
Qualcomm's Acquisition Hopes for Intel Diminish Amid Challenges
Canada Nickel Reaches Key Milestone in Impact Statement Process
Exploring the Commercial Bank Market Growth Opportunities Ahead
Exploring the Growth Dynamics of the Vacuum Cleaner Sector
Hyperscale Data's Innovative Approach to Shareholder Rewards
Spectrometry Market Expected to Reach USD 30.29 Billion by 2031
Chronic Wound Care Market Growth Forecast to 2031
Global Market Movements: Stocks Retreat as Gold and Oil Rise
Embecta Corp Updates Stakeholders on Financial Strategy and Results
Burlington Stores Achieves Remarkable Growth in Q3 2024
Titan Machinery Reports Fiscal Q3 Results Amid Market Cycles
Upcoming UBL Board Meeting: Focus on Non-Financial Matters
Dunedin Income Growth Trust Ensures Stability with New Rules
Ferguson Enterprises Announces First Quarter Results Date
Euro Zone Inflation Expectations Dip Below 2%: Key Insights
Adani Green's Ambitious Renewable Energy Goals Amid Controversy
Wells Fargo Anticipates Lift of Asset Cap Amid Regulatory Changes
Roche's Strategic Move: Acquiring Poseida for $1.5 Billion
Exxon Mobil's Commitment to Capital Discipline Amid Gains
Concerns Rise as UK Police Reassess Social Media Use
ProShares Bitcoin Short Funds See Unprecedented Investment Surge
Scott Bessent's Vision: Transforming the U.S. Economic Landscape
Three Tech and Telecom Stocks to Consider This Month
Fondul Proprietatea's Board Nominee Vote Preparation Insights
Albion Crown VCT Reports NAV Decline and Future Plans
Trump's Tariff Threat Sends Shockwaves Through Currency Markets
Medicare's New Proposal Could Revolutionize Obesity Treatments